Strategies for Targeted Gene Delivery Using Lipid Nanoparticles and Cell-derived Nanovesicles
Overview
Authors
Affiliations
Gene therapy is a promising approach for the treatment of many diseases. However, the effective delivery of the cargo without degradation is one of the major hurdles. With the advent of lipid nanoparticles (LNPs) and cell-derived nanovesicles (CDNs), gene delivery holds a very promising future. The targeting of these nanosystems is a prerequisite for effective transfection with minimal side-effects. In this review, we highlight the emerging strategies utilized for the effective targeting of LNPs and CDNs, and we summarize the preparation methodologies for LNPs and CDNs. We have also highlighted the non-ligand targeting of LNPs toward certain organs based on their composition. It is highly expected that continuing the developments in the targeting approaches of LNPs and CDNs for the delivery system will further promote them in clinical translation.
Nucleic Acid Conjugates: Unlocking Therapeutic Potential.
Kashyap D, Booth M ACS Bio Med Chem Au. 2025; 5(1):3-15.
PMID: 39990950 PMC: 11843337. DOI: 10.1021/acsbiomedchemau.4c00092.
Boosting Lipofection Efficiency Through Enhanced Membrane Fusion Mechanisms.
Pavlov R, Akimov S, Dashinimaev E, Bashkirov P Int J Mol Sci. 2025; 25(24.
PMID: 39769303 PMC: 11677079. DOI: 10.3390/ijms252413540.
Antigen-specific T cell immunotherapy by in vivo mRNA delivery.
Su F, Siebart J, Chan C, Wang M, Yao X, Trenkle A bioRxiv. 2024; .
PMID: 39554121 PMC: 11566043. DOI: 10.1101/2024.10.29.620946.
Haghighi E, Abolmaali S, Dehshahri A, Mousavi Shaegh S, Azarpira N, Tamaddon A J Nanobiotechnology. 2024; 22(1):710.
PMID: 39543630 PMC: 11566655. DOI: 10.1186/s12951-024-02972-w.
Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics.
Vasileva O, Zaborova O, Shmykov B, Ivanov R, Reshetnikov V Front Pharmacol. 2024; 15:1466337.
PMID: 39508050 PMC: 11537937. DOI: 10.3389/fphar.2024.1466337.